Patents by Inventor Hee Yoon Jeong

Hee Yoon Jeong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR ANTITUSSIVE, EXPECTORANT OR ANTI-INFLAMMATION
    Publication number: 20180214499
    Abstract: The present invention provides a composition containing, as active ingredients, Panax ginseng, Adenophora triphylla, Wolfiporia extensa, Rehmannia glutinosa, and Mel for an antitussive, expectorant, or anti-inflammatory action, and a composition for preventing, alleviating, or treating a respiratory disease. The present invention provides a compositions having excellent effects compared with an existing antitussive agent and expectorant agent. The compositions of the present invention are a naturally derived material and has little cytotoxicity, and thus is expected to be safely used as a medicine or food composition having antitussive, expectorant, and anti-inflammatory effects.
    Type: Application
    Filed: January 31, 2018
    Publication date: August 2, 2018
    Inventors: Seong Min KU, Tae Hun KU, Chul Jong JUNG, Yun Young CHO, Jeong Gyun SEO, Nam Oh KIM, Hee Yoon JEONG, Eun Sik CHOI, Hye Ran GONG, Sae Kwang KU
  • Pharmaceutical composition for preventing or treating diabetes containing TENC1 expression or activity suppressor
    Patent number: 9402856
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating diabetes or a complication of diabetes, which includes a TENC1 (tensin like C1 domain-containing phosphatase) expression or activity suppressor, and, more specifically, relates to a pharmaceutical composition for preventing or treating diabetes or a complication of diabetes, which either suppresses the degradation of IRS-1 (insulin receptor substrate-1) or suppresses the phosphorylation of IRS-1 due to the PTPase activity of TENC1.
    Type: Grant
    Filed: January 14, 2013
    Date of Patent: August 2, 2016
    Assignee: Postech Academy-Industry Foundation
    Inventors: Sung Ho Ryu, A Ra Koh, Mi Nam Lee, Hee Yoon Jeong, Yong Ryoul Yang, Pann Ghill Suh
  • Pharmaceutical Composition for Preventing or Treating Diabetes Containing TENC1 Expression or Activity Suppressor
    Publication number: 20150038551
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating diabetes or a complication of diabetes, which includes a TENC1 (tensin like C1 domain-containing phosphatase) expression or activity suppressor, and, more specifically, relates to a pharmaceutical composition for preventing or treating diabetes or a complication of diabetes, which either suppresses the degradation of IRS-1 (insulin receptor substrate-1) or suppresses the phosphorylation of IRS-1 due to the PTPase activity of TENC1.
    Type: Application
    Filed: January 14, 2013
    Publication date: February 5, 2015
    Applicant: POSTECH ACADEMY-INDUSTRY FOUNDATION
    Inventors: Sung Ho Ryu, A. Ra Koh, Mi Nam Lee, Hee Yoon Jeong, Yong Ryoul Yang, Pann Ghill Suh